- Investing.com
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, rest of the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Financial Resilience | Teleflex demonstrates adaptability amidst challenges, adjusting guidance while maintaining profitability through effective cost management and strategic initiatives |
Market Dynamics | Explore Teleflex's navigation of complex market forces, from unexpected customer losses to promising growth in key segments like Intra-Aortic Balloon Pumps |
Strategic Vision | Delve into Teleflex's growth strategy, combining organic expansion with strategic acquisitions to strengthen market position and drive innovation |
Analyst Outlook | Price targets range from $210 to $285, reflecting varied optimism about Teleflex's future prospects and ability to overcome current headwinds |
Metrics to compare | TFX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTFXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 90.0x | 12.7x | −0.5x | |
PEG Ratio | −0.06 | −6.54 | 0.00 | |
Price/Book | 1.7x | 4.0x | 2.6x | |
Price / LTM Sales | 2.6x | 2.6x | 3.2x | |
Upside (Analyst Target) | 13.3% | 22.3% | 50.1% | |
Fair Value Upside | Unlock | 8.7% | 8.6% | Unlock |